*Department of Neurology, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, U.S.A.;
†Department of Neurology, Epilepsy Unit Montpellier, Montpellier, France;
‡Intensive Care Units and Department of Neurology, University Hospital Basel, Basel, Switzerland; and
§University of Basel, Basel, Switzerland.
Address correspondence and reprint requests to Peter W. Kaplan, FRCP, MD, Department of Neurology, JHBMC 301 Building, 4940 Eastern Ave, Baltimore, MD 21224, U.S.A.; e-mail: [email protected].
P. W. Kaplan has no conflicts of interest relevant to this article. He has been on the board of the American Board of Clinical Neurophysiology and lectured on EEG. P. Gelisse reports no conflicts of interest relevant to this article. R. Sutter has no conflicts of interest relevant to this article. He has received research grants from the Swiss National Foundation (No 320030_169379), the Research Fund of the University Basel, the Scientific Society Basel, and the Bangerter-Rhyner Foundation. He received personal grants from UCB-pharma, and holds stocks from Novartis, Roche, Alcon, and Johnson & Johnson.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.clinicalneurophys.com).
